Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer
Open Access
- 17 January 2026
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Abstract
Breast cancer (BC) is one of the most common types of cancer among women, leading to death. More than 90% of deaths from BC are due to hematogenous metastases. In the cellular and tissue levels, the aggressiveness of BC is linked with epithelial–mesenchymal transition, leading to enhanced cell motility and spread in the bloodstream, leading to tumor expansion. This review focuses on the vascular mechanisms that facilitate metastatic dissemination in BC, highlighting the influence of blood vessels, hemodynamic forces, and vascular microenvironmental properties on tumor cell spread. Particular emphasis is placed on the role of endothelial dysfunction within common comorbid conditions and how these alterations may increase metastatic propensity. In addition, we discussed whether improving endothelial health and effectively managing comorbidities could help reduce metastatic progression.Keywords
This publication has 130 references indexed in Scilit:
- Cardiovascular Disease and Breast Cancer Stage at DiagnosisJAMA Network Open, 2025
- Endothelial dysfunction: molecular mechanisms and clinical implicationsMedcomm, 2024
- Examining hypertension risk among Black and White breast cancer survivorsCancer Medicine, 2024
- Postmenopausal overweight and breast cancer risk; results from the KARMA cohortBreast Cancer Research and Treatment, 2022
- Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancerCancer, 2021
- Association of Obesity With Survival Outcomes in Patients With CancerJAMA Network Open, 2021
- Visualizing cancer extravasation: from mechanistic studies to drug developmentCancer and Metastasis Reviews, 2020
- Vascular co-option in brain metastasisAngiogenesis, 2019
- Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and Molecular Life Sciences, 2019
- Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis modelsThe Journal of Pathology, 2016